Research & Clinical Summary

HIV and herpesvirus vaccine development
Herpes simplex virus type 2 (HSV-2) pathogenesis and the host immune response
Immunotherapeutic approaches to viral infections and cancer

Teaching and Mentoring Interests

Virology
Viral immunology
Development of novel therapies for viral infections

Current Studies

Mucosal immunity of viral infections
Spatial and functional characterization of tissue resident immune responses at the site of herpesvirus or HIV infection
Spatial dynamics and function of adoptively transferred or vaccine induced T cells
CAR T cells as a modality to achieve HIV-1 cure

Publications

The following publications were retrieved from PubMed:

Taylor MM, Chohan B, Lavreys L, Hassan W, Huang ML, Corey L, Ashley Morrow R, Richardson BA, Mandaliya K, Ndinya-Achola J, Bwayo J, Kreiss J,
“Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women.”
The Journal of infectious diseases 190.3 (2004 Aug 1): 484-8.

Blower S, Wald A, Gershengorn H, Wang F, Corey L,
“Targeting virological core groups: a new paradigm for controlling herpes simplex virus type 2 epidemics.”
The Journal of infectious diseases 190.9 (2004 Nov 1): 1610-7.

Magaret AS, Wald A, Huang ML, Selke S, Corey L,
“Optimizing PCR positivity criterion for detection of herpes simplex virus DNA on skin and mucosa.”
Journal of clinical microbiology 45.5 (2007 May): 1618-20.

Woolfrey AE, Malhotra U, Harrington RD, McNevin J, Manley TJ, Riddell SR, Coombs RW, Appelbaum FR, Corey L, Storb R,
“Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation.”
Blood 112.8 (2008 Oct 15): 3484-7.

Scott J, Holte S, Urban T, Burgess C, Coppel E, Wang C, Corey L, McHutchison J, Goldstein D,
“IL28B genotype effects during early treatment with peginterferon and ribavirin in difficult-to-treat hepatitis C virus infection.”
The Journal of infectious diseases 204.3 (2011 Aug 1): 419-25.

Corey L,
“Back to the bench.”
IAVI report : newsletter on international AIDS vaccine research 18.2 (2014): 15-7.

Jin X, Morgan C, Yu X, DeRosa S, Tomaras GD, Montefiori DC, Kublin J, Corey L, Keefer MC, NIAID HIV Vaccine Trials Network.,
“Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials.”
Vaccine 33.20 (2015 May 11): 2347-53.